Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484130 · ClinicalTrials.gov registry record
Prospective Phenotyping of Autonomous Aldosterone Secretion
A clinical trial of Blood Pressure and Aldosterone Disorder, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03484130: Active study of Blood Pressure and Aldosterone Disorder, sponsored by Brigham and Women's Hospital.
NCT03484130 is a study of Blood Pressure and Aldosterone Disorder that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 100 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03484130, a study of Blood Pressure and Aldosterone Disorder, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective cohort study will investigate the physiology and progression of autonomous aldosterone secretion.
Primary Outcome
The primary outcome is to evaluate the longitudinal change in plasma renin activity
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sodium loaded diet
- DIETARY_SUPPLEMENT Restricted sodium diet
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2029-07-01 |
What the registry record for NCT03484130 still lists
NCT03484130 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (65% lower).
The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Sodium loaded diet is the first listed.
NCT03484130 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03484130 about?
NCT03484130 is a clinical study titled "Prospective Phenotyping of Autonomous Aldosterone Secretion". This prospective cohort study will investigate the physiology and progression of autonomous aldosterone secretion.
What is the current status of trial NCT03484130?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2018-06-15. Estimated completion is 2029-07-01.
What conditions does trial NCT03484130 study?
This clinical trial studies the following conditions: Blood Pressure, Aldosterone Disorder, Adrenal Gland Disease.
What interventions are being tested in trial NCT03484130?
The interventions under investigation include: Sodium loaded diet (DIETARY_SUPPLEMENT), Restricted sodium diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03484130?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03484130 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03484130's enrollment target sits among peer trials
100 38th of 101 higher than 63 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
VicorderCS NIBP Validation Study to Review The Ability to Capture Blood Pressure Measurements
RECRUITING
-
The GUARDIAN Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI